COVID-19 pills could be game-changer, but doctors worry about early access

12/18/2021 | by | Uncategorized

Merck and Pfizer are each nearing authorization for their therapeutics.
Source: Test feed

Leave a Comment

Your email address will not be published.

*
*
*